Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized Double-Blind Study to Assess the Skin Irritation and Sensitization Potential of Once-Weekly Corplex Donepezil Transdermal Delivery System

Trial Profile

A Randomized Double-Blind Study to Assess the Skin Irritation and Sensitization Potential of Once-Weekly Corplex Donepezil Transdermal Delivery System

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Sep 2018

At a glance

  • Drugs Donepezil (Primary)
  • Indications Alzheimer's disease
  • Focus Adverse reactions
  • Sponsors Corium International
  • Most Recent Events

    • 13 Sep 2018 Status changed from active, no longer recruiting to completed.
    • 16 Jul 2018 Planned End Date changed from 1 May 2018 to 1 Oct 2018.
    • 16 Jul 2018 Planned primary completion date changed from 1 May 2018 to 1 Jul 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top